The pharmacist's contribution to the pharmacological treatment of depression: a review
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | por eng |
Título da fonte: | Scire Salutis |
Texto Completo: | https://sustenere.inf.br/index.php/sciresalutis/article/view/6433 |
Resumo: | Pharmaceutical care concerns the proper guidance to the patient, in cases involving depression it is important to understand which the main aspect will be harmed by the disease, and in cases where depression occurs through pressure in the work environment, it is important to understand that the drugs administered cannot cause extreme drowsiness in the patient, as he will need to readjust his work routine using the medication. To analyze the pharmacological treatment of depression through antidepressants and the contribution of the pharmacist as a guide for drug use. Integrative literature review supported by the following databases NCBI/PubMed (National Center for BiotechnologyInformation), SciELO (Scientific Electronic Lirary Online), Academic Google and Lilacs - Bireme (Latin American and Caribbean Literature in Sciences of the Health). To delimit the contents, inclusion criteria were used: articles available in full, in Portuguese and English, from 2014 to 2021 with free access and that were relevant to the theme. In the ten articles analyzed, depression is presented as a disease that requires immediate pharmacological intervention, the promotion of health and quality of life in all areas of life, including at work, it is necessary that the pharmacist promote a clear guidance and ensuring patient safety in the use of drugs. It was concluded that the pharmacist is the professional trained to reinforce the guidance on the use of psychotropic drugs, as well as to analyze the patient's evolution, and to understand the nuances of pressure in the work environment is essential for guidance on the medications that do not cause extreme drowsiness to the patient. |
id |
ESS-1_8f84af12cebe3cd34e92e766a15792a3 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/6433 |
network_acronym_str |
ESS-1 |
network_name_str |
Scire Salutis |
repository_id_str |
|
spelling |
The pharmacist's contribution to the pharmacological treatment of depression: a reviewA contribuição do farmacêutico no tratamento farmacológico da depressão: uma revisãoPsicotrópicosSonolênciaDepressãoFarmacologiaPsychotropicsSomnolenceDepressionPharmacologyPharmaceutical care concerns the proper guidance to the patient, in cases involving depression it is important to understand which the main aspect will be harmed by the disease, and in cases where depression occurs through pressure in the work environment, it is important to understand that the drugs administered cannot cause extreme drowsiness in the patient, as he will need to readjust his work routine using the medication. To analyze the pharmacological treatment of depression through antidepressants and the contribution of the pharmacist as a guide for drug use. Integrative literature review supported by the following databases NCBI/PubMed (National Center for BiotechnologyInformation), SciELO (Scientific Electronic Lirary Online), Academic Google and Lilacs - Bireme (Latin American and Caribbean Literature in Sciences of the Health). To delimit the contents, inclusion criteria were used: articles available in full, in Portuguese and English, from 2014 to 2021 with free access and that were relevant to the theme. In the ten articles analyzed, depression is presented as a disease that requires immediate pharmacological intervention, the promotion of health and quality of life in all areas of life, including at work, it is necessary that the pharmacist promote a clear guidance and ensuring patient safety in the use of drugs. It was concluded that the pharmacist is the professional trained to reinforce the guidance on the use of psychotropic drugs, as well as to analyze the patient's evolution, and to understand the nuances of pressure in the work environment is essential for guidance on the medications that do not cause extreme drowsiness to the patient.A atenção farmacêutica diz respeito à orientação adequada ao paciente, nos casos que envolvem depressão é importante compreender qual o principal aspecto será prejudicado pela doença, e nos casos em que a depressão ocorre através da pressão no ambiente de trabalho é importante compreender que os fármacos ministrados não podem causar uma extrema sonolência no paciente, pois, este precisará se readequar a sua rotina de trabalho fazendo uso da medicação. Analisar o tratamento farmacológico na depressão através dos antidepressivos e da contribuição do farmacêutico enquanto orientador para utilização medicamentosa. Revisão integrativa de literatura com suporte das seguintes bases de dados NCBI/PubMed (National Center for BiotechnologyInformation), SciELO (Scientific Eletronic Lirary Online), Google Acadêmico e Lilacs - Bireme (Literatura Latino-Americana e do Caribe em Ciências da Saúde). Para delimitação dos conteúdos foram utilizados critérios de inclusão: artigos disponíveis na integra, em português e inglês, no período de 2014 a 2021 com acesso gratuito e que tivessem pertinência com tema. Nos dez artigos analisados a depressão se apresenta enquanto uma doença que requer intervenção farmacológica de forma imediata, a promoção da saúde e da qualidade de vida em todos os âmbitos da vida, inclusive no trabalho, é necessária que o farmacêutico promova uma orientação clara e que garanta a segurança do paciente na utilização dos fármacos. Concluiu-se que o farmacêutico é o profissional capacitado para reforçar a orientação sobre a utilização dos psicotrópicos, bem como, analisar a evolução do paciente, e compreender as nuances da pressão no ambiente de trabalho é fundamental para orientação sobre os medicamentos que não causem uma extrema sonolência ao paciente.Sustenere Publishing2021-10-22info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://sustenere.inf.br/index.php/sciresalutis/article/view/643310.6008/CBPC2236-9600.2022.001.0009Scire Salutis; Vol. 12 No. 1 (2022): Scire Salutis - Out, Nov, Dez 2021, Jan 2022; 74-81Scire Salutis; Vol. 12 Núm. 1 (2022): Scire Salutis - Out, Nov, Dez 2021, Jan 2022; 74-81Scire Salutis; v. 12 n. 1 (2022): Scire Salutis - Out, Nov, Dez 2021, Jan 2022; 74-812236-9600reponame:Scire Salutisinstname:Companhia Brasileira de Produção Científica (CBPC)instacron:ESSporenghttps://sustenere.inf.br/index.php/sciresalutis/article/view/6433/3449https://sustenere.inf.br/index.php/sciresalutis/article/view/6433/3478Copyright (c) 2021 Scire Salutishttp://creativecommons.org/licenses/by-nc-nd/4.0info:eu-repo/semantics/openAccessVargas, Izabela MartinsMartins, Patrícia Santos Marquez, Carolinne de Oliveira 2023-01-04T20:16:22Zoai:ojs.pkp.sfu.ca:article/6433Revistahttps://sustenere.co/index.php/sciresalutisONGhttps://sustenere.co/index.php/sciresalutis/oai||carlos@arvore.org.br2236-96002236-9600opendoar:2023-01-04T20:16:22Scire Salutis - Companhia Brasileira de Produção Científica (CBPC)false |
dc.title.none.fl_str_mv |
The pharmacist's contribution to the pharmacological treatment of depression: a review A contribuição do farmacêutico no tratamento farmacológico da depressão: uma revisão |
title |
The pharmacist's contribution to the pharmacological treatment of depression: a review |
spellingShingle |
The pharmacist's contribution to the pharmacological treatment of depression: a review Vargas, Izabela Martins Psicotrópicos Sonolência Depressão Farmacologia Psychotropics Somnolence Depression Pharmacology |
title_short |
The pharmacist's contribution to the pharmacological treatment of depression: a review |
title_full |
The pharmacist's contribution to the pharmacological treatment of depression: a review |
title_fullStr |
The pharmacist's contribution to the pharmacological treatment of depression: a review |
title_full_unstemmed |
The pharmacist's contribution to the pharmacological treatment of depression: a review |
title_sort |
The pharmacist's contribution to the pharmacological treatment of depression: a review |
author |
Vargas, Izabela Martins |
author_facet |
Vargas, Izabela Martins Martins, Patrícia Santos Marquez, Carolinne de Oliveira |
author_role |
author |
author2 |
Martins, Patrícia Santos Marquez, Carolinne de Oliveira |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Vargas, Izabela Martins Martins, Patrícia Santos Marquez, Carolinne de Oliveira |
dc.subject.por.fl_str_mv |
Psicotrópicos Sonolência Depressão Farmacologia Psychotropics Somnolence Depression Pharmacology |
topic |
Psicotrópicos Sonolência Depressão Farmacologia Psychotropics Somnolence Depression Pharmacology |
description |
Pharmaceutical care concerns the proper guidance to the patient, in cases involving depression it is important to understand which the main aspect will be harmed by the disease, and in cases where depression occurs through pressure in the work environment, it is important to understand that the drugs administered cannot cause extreme drowsiness in the patient, as he will need to readjust his work routine using the medication. To analyze the pharmacological treatment of depression through antidepressants and the contribution of the pharmacist as a guide for drug use. Integrative literature review supported by the following databases NCBI/PubMed (National Center for BiotechnologyInformation), SciELO (Scientific Electronic Lirary Online), Academic Google and Lilacs - Bireme (Latin American and Caribbean Literature in Sciences of the Health). To delimit the contents, inclusion criteria were used: articles available in full, in Portuguese and English, from 2014 to 2021 with free access and that were relevant to the theme. In the ten articles analyzed, depression is presented as a disease that requires immediate pharmacological intervention, the promotion of health and quality of life in all areas of life, including at work, it is necessary that the pharmacist promote a clear guidance and ensuring patient safety in the use of drugs. It was concluded that the pharmacist is the professional trained to reinforce the guidance on the use of psychotropic drugs, as well as to analyze the patient's evolution, and to understand the nuances of pressure in the work environment is essential for guidance on the medications that do not cause extreme drowsiness to the patient. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-10-22 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://sustenere.inf.br/index.php/sciresalutis/article/view/6433 10.6008/CBPC2236-9600.2022.001.0009 |
url |
https://sustenere.inf.br/index.php/sciresalutis/article/view/6433 |
identifier_str_mv |
10.6008/CBPC2236-9600.2022.001.0009 |
dc.language.iso.fl_str_mv |
por eng |
language |
por eng |
dc.relation.none.fl_str_mv |
https://sustenere.inf.br/index.php/sciresalutis/article/view/6433/3449 https://sustenere.inf.br/index.php/sciresalutis/article/view/6433/3478 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2021 Scire Salutis http://creativecommons.org/licenses/by-nc-nd/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2021 Scire Salutis http://creativecommons.org/licenses/by-nc-nd/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Sustenere Publishing |
publisher.none.fl_str_mv |
Sustenere Publishing |
dc.source.none.fl_str_mv |
Scire Salutis; Vol. 12 No. 1 (2022): Scire Salutis - Out, Nov, Dez 2021, Jan 2022; 74-81 Scire Salutis; Vol. 12 Núm. 1 (2022): Scire Salutis - Out, Nov, Dez 2021, Jan 2022; 74-81 Scire Salutis; v. 12 n. 1 (2022): Scire Salutis - Out, Nov, Dez 2021, Jan 2022; 74-81 2236-9600 reponame:Scire Salutis instname:Companhia Brasileira de Produção Científica (CBPC) instacron:ESS |
instname_str |
Companhia Brasileira de Produção Científica (CBPC) |
instacron_str |
ESS |
institution |
ESS |
reponame_str |
Scire Salutis |
collection |
Scire Salutis |
repository.name.fl_str_mv |
Scire Salutis - Companhia Brasileira de Produção Científica (CBPC) |
repository.mail.fl_str_mv |
||carlos@arvore.org.br |
_version_ |
1793890278446202880 |